These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15341554)

  • 1. A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine "ba wei di huang wan" in the treatment of dementia.
    Iwasaki K; Kobayashi S; Chimura Y; Taguchi M; Inoue K; Cho S; Akiba T; Arai H; Cyong JC; Sasaki H
    J Am Geriatr Soc; 2004 Sep; 52(9):1518-21. PubMed ID: 15341554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.
    Iwasaki K; Satoh-Nakagawa T; Maruyama M; Monma Y; Nemoto M; Tomita N; Tanji H; Fujiwara H; Seki T; Fujii M; Arai H; Sasaki H
    J Clin Psychiatry; 2005 Feb; 66(2):248-52. PubMed ID: 15705012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson's disease dementia.
    Gu C; Shen T; An H; Yuan C; Zhou J; Ye Q; Liu T; Wang X; Zhang T
    Neurosci Lett; 2015 Oct; 606():13-7. PubMed ID: 26297124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chinese herbal medicine, choto-san, improves cognitive function and activities of daily living of patients with dementia: a double-blind, randomized, placebo-controlled study.
    Suzuki T; Futami S; Igari Y; Matsumura N; Watanabe K; Nakano H; Oba K; Murata Y; Koibuchi H; Kigawa Y
    J Am Geriatr Soc; 2005 Dec; 53(12):2238-40. PubMed ID: 16398922
    [No Abstract]   [Full Text] [Related]  

  • 5. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.
    Mizukami K; Asada T; Kinoshita T; Tanaka K; Sonohara K; Nakai R; Yamaguchi K; Hanyu H; Kanaya K; Takao T; Okada M; Kudo S; Kotoku H; Iwakiri M; Kurita H; Miyamura T; Kawasaki Y; Omori K; Shiozaki K; Odawara T; Suzuki T; Yamada S; Nakamura Y; Toba K
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):191-9. PubMed ID: 19079814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.
    Chua KK; Wong A; Kwan PW; Song JX; Chen LL; Chan AL; Lu JH; Mok V; Li M
    Trials; 2015 Apr; 16():199. PubMed ID: 25925312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical study on a randomized, double-blind control of Chinese medicine granules in treatment of vascular dementia].
    Zhu AH; Tian JZ; Zhong J; Yang CZ; Shi J; Yin JX
    Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(20):1722-5. PubMed ID: 17225547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: a population-based case control study.
    Hsu PC; Tsai YT; Lai JN; Wu CT; Lin SK; Huang CY
    J Ethnopharmacol; 2014 Oct; 156():358-64. PubMed ID: 25178949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Chinese medicine for promoting blood circulation and removing blood stasis in treating patients with mild to moderate vascular dementia: a randomized, double-blind and parallel-controlled trial.
    Wei MQ; Tian JZ; Shi J; Ma FY; Miao YC; Wang YY
    Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1240-6. PubMed ID: 23158942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: a randomized, double-blind, placebo-controlled, trial.
    Kim J; Chung SY; Park S; Park JH; Byun S; Hwang M; Oh DS; Choi H; Kim MY; Bu YC; Doré S; Whang WW; Kim H
    Pharmacol Biochem Behav; 2008 Oct; 90(4):517-24. PubMed ID: 18550156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of banxia houpu tang, a traditional Chinese medicine, for reducing pneumonia risk in older adults with dementia.
    Iwasaki K; Kato S; Monma Y; Niu K; Ohrui T; Okitsu R; Higuchi S; Ozaki S; Kaneko N; Seki T; Nakayama K; Furukawa K; Fujii M; Arai H
    J Am Geriatr Soc; 2007 Dec; 55(12):2035-40. PubMed ID: 17944889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence.
    Lackner TE; Wyman JF; McCarthy TC; Monigold M; Davey C
    J Am Geriatr Soc; 2008 May; 56(5):862-70. PubMed ID: 18410326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
    Geleijnse JM; Giltay EJ; Kromhout D
    Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of Fufangdanshen tablets (Radix Salviae miltiorrhizae formula tablets) for mild to moderate vascular dementia: a study protocol for a randomized controlled trial.
    Tian J; Shi J; Wei M; Qin R; Ni J; Zhang X; Li T; Wang Y
    Trials; 2016 Jun; 17(1):281. PubMed ID: 27266867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.
    Farlow M; Potkin S; Koumaras B; Veach J; Mirski D
    Arch Neurol; 2003 Jun; 60(6):843-8. PubMed ID: 12810489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.